Hope for teens with schizophrenia: new drug trial launches
Disease control
Recruiting now
This study tests whether cariprazine, a medicine already used in adults, can safely reduce schizophrenia symptoms in teenagers aged 13 to 17. About 330 teens will receive either cariprazine or a placebo for 6 weeks. The main goal is to see if symptoms improve more with the active…
Phase: PHASE3 • Sponsor: Gedeon Richter Plc. • Aim: Disease control
Last updated Apr 24, 2026 16:07 UTC